Comparing access to new medicines by therapeutic class in public and private sector plans in Canada.


Author: CHPI Annual Report

This study is Part 2 of CHPI’s annual series of reports published under the title: How good is your drug insurance? This edition compares the generosity of coverage for new drugs in public (federal and provincial) and private insurance plans in Canada within five select therapeutic classes. Presenting the data separately by therapeutic class allows us to see how particular patient populations are uniquely impacted by differences in drug insurance benefits.